The legacy of Sildenafil offers a complex case study for investors eyeing pharma. While first sales were remarkable, current patent lapse and the emergence of cheaper versions have significantly affected revenues. https://agnesdeso360207.yomoblog.com/48323454/viagra-and-pharma-a-dangerous-stake